Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Market Cap	3.97Cr 4.61Cr 3.76Cr 3.41Cr 6.39Cr 440.4Cr 6.43Cr 45Cr 17Cr 223.86Cr 17Cr 17Cr 704.52Cr	P/E 2026 *	-7.69x	P/E 2027 *	57.7x
Enterprise Value	5.09Cr 5.9Cr 4.82Cr 4.37Cr 8.19Cr 563.94Cr 8.23Cr 57Cr 22Cr 286.66Cr 22Cr 22Cr 902.15Cr	EV / Sales 2026 *	9.98x	EV / Sales 2027 *	3.32x
Free-Float	87.09%	Yield 2026 *	-	Yield 2027 *	-

09/09	Amoéba, Syngenta Sign European Distribution Deal for Biocontrol Fungicide	MT
24/07	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
01/07	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
30/06	Amoéba gains from marketing authorization in France
30/06	Amoéba Bags Marketing Approval for Biofungicide in France	MT
30/06	Amoéba wins marketing authorization in France
09/06	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
08/06	Amoéba secures strategic emergency authorization in Italy
07/05	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
29/04	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
28/04	Amoéba secures emergency authorization for downy mildew treatment in France
14/04	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI
26/03	Amoéba Raises EUR7 Million via Private Placement	MT

10/09	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL
09/09	Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	GL
08/09	Amoéba : Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers	AT
23/07	Amoéba : Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides	AT
01/07	Amoéba has received marketing authorization in France for its biofungicide AXPERA	GL

10/09	Syngenta en Amoéba hebben een exclusieve distributieovereenkomst in Europa gesloten om graanproducenten een innoverend biofungicide te bieden
10/09	Syngenta e Amoéba hanno concluso un accordo di distribuzione esclusiva in Europa per proporre ai produttori di cereali un'innovazione biofungicida
10/09	Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
10/09	Syngenta y Amoéba han suscrito un acuerdo de distribución exclusiva en Europa para ofrecer una innovación biofungicida a los productores cerealistas
10/09	Syngenta und Amoéba schließen exklusiven europäischen Vertriebsvertrag, um Getreideerzeugern ein wegweisendes Biofungizid bereitzustellen

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	14/12/2023
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	01/09/2018
Jean-Baptiste Eberst LAW	General Counsel	-	01/07/2015

Amoéba Share Price Euronext Paris

Stocks

Agricultural Chemicals

Valuation : Amoéba

Latest news : Amoéba

Press Releases : Amoéba

News in other languages : Amoéba

Managers and Directors : Amoéba

Pesticide

Financials

Company Profile

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	01/06/2014
Benoît Villers CHM	Chairman	70	14/12/2023
Jean-luc Souche BRD	Director/Board Member	70	25/05/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	-.--%	-11.21%	-	-	4.61Cr
JIANGSU YANGNONG CHEMICAL CO., LTD.	-4.64%	-2.56%	-27.62%	-17.37%	325.82Cr
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO.,LTD	+3.91%	+13.34%	+12.22%	+19.87%	251.26Cr
ADAMA LTD.	-3.03%	+1.94%	-16.62%	-29.03%	192.87Cr
LIER CHEMICAL CO.,LTD.	+1.20%	+1.95%	+22.77%	+14.43%	180.76Cr
SHENZHEN NOPOSION CROP SCIENCE CO., LTD.	-3.63%	-4.90%	-17.48%	+47.23%	148.96Cr
CAC NANTONG CHEMICAL CO., LTD.	-2.13%	-5.19%	-28.99%	-	148.17Cr
ANHUI GUANGXIN AGROCHEMICAL CO., LTD.	-2.62%	+0.09%	-10.84%	-46.90%	146.27Cr
NANTONG JIANGSHAN AGROCHEMICAL & CHEMICALS CO.,LTD.	-4.09%	+0.16%	-28.66%	-11.77%	120.3Cr
LIMIN GROUP CO.,LTD.	-5.49%	-4.70%	-18.19%	+84.45%	112.55Cr
Average	-2.05%	-0.23%	-12.60%	+7.61%	180.77Cr
Weighted average by Cap.	-1.99%	+0.52%	-11.68%	+3.11%

	2026 *	2027 *
Net sales	51L 59.14L 48.28L 43.75L 82.03L 57Cr 82.47L 5.73Cr 2.2Cr 29Cr 2.22Cr 2.17Cr 90Cr	1.56Cr 1.8Cr 1.47Cr 1.33Cr 2.5Cr 172.29Cr 2.51Cr 17Cr 6.72Cr 88Cr 6.77Cr 6.62Cr 275.62Cr
Net income	-52L -60.3L -49.23L -44.61L -83.64L -58Cr -84.09L -5.84Cr -2.25Cr -29Cr -2.26Cr -2.21Cr -92Cr	6L 6L 5L 5L 9L 6.09Cr 9L 61.8L 23.77L 3.1Cr 23.96L 23.43L 9.75Cr
Net Debt	1.12Cr 1.29Cr 1.06Cr 95.66L 1.79Cr 123.54Cr 1.8Cr 13Cr 4.82Cr 63Cr 4.86Cr 4.75Cr 197.63Cr	1.18Cr 1.37Cr 1.12Cr 1.02Cr 1.91Cr 131.3Cr 1.92Cr 13Cr 5.12Cr 67Cr 5.16Cr 5.05Cr 210.04Cr